HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel A Spyker Selected Research

Loxapine (Loxitane)

11/2017Response to inhaled loxapine in patients with schizophrenia or bipolar I disorder: PANSS-EC responder analyses.
12/2014Safety and tolerability of inhaled loxapine in subjects with asthma and chronic obstructive pulmonary disease--two randomized controlled trials.
10/2014Effect of smoking on the pharmacokinetics of inhaled loxapine.
2/2012Rapid acute treatment of agitation in patients with bipolar I disorder: a multicenter, randomized, placebo-controlled clinical trial with inhaled loxapine.
10/2011Efficacy and safety of loxapine for inhalation in the treatment of agitation in patients with schizophrenia: a randomized, double-blind, placebo-controlled trial.
1/2011Rapid acute treatment of agitation in individuals with schizophrenia: multicentre, randomised, placebo-controlled study of inhaled loxapine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel A Spyker Research Topics

Disease

13Foreign Bodies (Foreign Body)
12/2021 - 12/2009
8Poisoning
01/2021 - 06/2006
5Schizophrenia (Dementia Praecox)
11/2017 - 01/2011
3Bipolar Disorder (Manic Depressive Psychosis)
12/2014 - 02/2012
1COVID-19
01/2022
1Headache (Headaches)
01/2022
1End Stage Liver Disease
01/2021
1Brain Diseases (Brain Disorder)
01/2021
1Cough
03/2016
1Human Influenza (Influenza)
03/2016
1Drug Overdose
04/2015
1Asthma (Bronchial Asthma)
12/2014
1Bronchial Spasm
12/2014
1Chronic Obstructive Pulmonary Disease (COPD)
12/2014
1Breakthrough Pain
11/2012
1Dysgeusia (Parageusia)
02/2012
1Psychotic Disorders (Schizoaffective Disorder)
10/2011
1Hypotension (Low Blood Pressure)
08/2010
1Anaphylaxis (Anaphylactic Shock)
10/2009
1Migraine Disorders (Migraine)
11/2006

Drug/Important Bio-Agent (IBA)

13CosmeticsIBA
12/2021 - 12/2009
13Analgesics (Analgesic Drugs)IBA
12/2021 - 12/2009
6Acetaminophen (Paracetamol)FDA LinkGeneric
01/2021 - 10/2009
6Loxapine (Loxitane)FDA LinkGeneric
11/2017 - 01/2011
6Antipsychotic Agents (Antipsychotics)IBA
12/2014 - 12/2009
5Hypnotics and Sedatives (Sedatives)IBA
12/2013 - 12/2009
4PoisonsIBA
01/2022 - 08/2010
2Opioid Analgesics (Opioids)IBA
04/2015 - 11/2012
2AerosolsIBA
10/2014 - 11/2006
1COVID-19 VaccinesIBA
01/2022
1VaccinesIBA
01/2022
1SolutionsIBA
01/2022
1Lactic Acid (Lactate)FDA LinkGeneric
01/2021
1Phosphates (Orthophosphate)IBA
01/2021
1Antidepressive Agents (Antidepressants)IBA
12/2019
1Promethazine (Promet)FDA LinkGeneric
03/2016
1SaltsIBA
04/2015
1Detergents (Detergent)IBA
04/2015
1CannabinoidsIBA
04/2015
1Albuterol (Salbutamol)FDA LinkGeneric
12/2014
1Bronchodilator Agents (Bronchodilators)IBA
12/2014
1PowdersIBA
10/2014
1Pharmaceutical PreparationsIBA
02/2012
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
08/2010
1Amlodipine (Norvasc)FDA LinkGeneric
08/2010
1Acetylcysteine (Siran)FDA LinkGeneric
10/2009
1AntiemeticsIBA
11/2006
1Alprazolam (Xanax)FDA LinkGeneric
11/2006
1Prochlorperazine (Compazine)FDA LinkGeneric
11/2006
1Clonidine (ST 155)FDA LinkGeneric
06/2006

Therapy/Procedure

1Nebulizers and Vaporizers (Inhaler)
10/2011